Molecular profiling of individual tumor cells by hyperspectral microscopic imaging

Jonathan W. Uhr, Michael L. Huebschman, Eugene P. Frenkel, Nancy L. Lane, Raheela Ashfaq, Huaying Liu, Dipen R. Rana, Lawrence Cheng, Alice T. Lin, Gareth A. Hughes, Xiaojing J. Zhang, Harold R. Garner

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

We developed a hyperspectral microscopic imaging (HMI) platform that can precisely identify and quantify 10 molecular markers in individual cancer cells in a single pass. The exploitation of an improved separation of circulating tumor cells and the application of HMI provided an opportunity (1) to identify molecular changes in these cells, (2) to recognize the coexpression of these markers, (3) to pose an important opportunity for noninvasive diagnosis, and (4) to use targeted therapy. We balanced the intensity of 10 fluorochromes bound to 10 different antibodies, each specific to a particular tumor marker, so that the intensity of each fluorochrome can be discerned from overlapping emissions. Using 2 touch preps from each primary breast cancer, the average molecular marker intensities of 25 tumor cells gave a representative molecular signature for the tumor despite some cellular heterogeneity. The intensities determined by the HMI correlate well with the conventional 0-3+ analysis by experts in cellular pathology. Because additional multiplexes can be developed using the same fluorochromes but different antibodies, this analysis allows quantification of many molecular markers on a population of tumor cells. HMI can be automated completely, and eventually, it could allow the standardization of protein biomarkers and improve reproducibility among clinical pathology laboratories.

Original languageEnglish (US)
Pages (from-to)366-375
Number of pages10
JournalTranslational Research
Volume159
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Tumors
Fluorescent Dyes
Cells
Imaging techniques
Pathology
Neoplasms
Circulating Neoplastic Cells
Clinical Pathology
Antibodies
Touch
Biomarkers
Tumor Biomarkers
Standardization
Breast Neoplasms
Population
Proteins
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, medical
  • Public Health, Environmental and Occupational Health

Cite this

Uhr, J. W., Huebschman, M. L., Frenkel, E. P., Lane, N. L., Ashfaq, R., Liu, H., ... Garner, H. R. (2012). Molecular profiling of individual tumor cells by hyperspectral microscopic imaging. Translational Research, 159(5), 366-375. https://doi.org/10.1016/j.trsl.2011.08.003

Molecular profiling of individual tumor cells by hyperspectral microscopic imaging. / Uhr, Jonathan W.; Huebschman, Michael L.; Frenkel, Eugene P.; Lane, Nancy L.; Ashfaq, Raheela; Liu, Huaying; Rana, Dipen R.; Cheng, Lawrence; Lin, Alice T.; Hughes, Gareth A.; Zhang, Xiaojing J.; Garner, Harold R.

In: Translational Research, Vol. 159, No. 5, 05.2012, p. 366-375.

Research output: Contribution to journalArticle

Uhr, JW, Huebschman, ML, Frenkel, EP, Lane, NL, Ashfaq, R, Liu, H, Rana, DR, Cheng, L, Lin, AT, Hughes, GA, Zhang, XJ & Garner, HR 2012, 'Molecular profiling of individual tumor cells by hyperspectral microscopic imaging', Translational Research, vol. 159, no. 5, pp. 366-375. https://doi.org/10.1016/j.trsl.2011.08.003
Uhr, Jonathan W. ; Huebschman, Michael L. ; Frenkel, Eugene P. ; Lane, Nancy L. ; Ashfaq, Raheela ; Liu, Huaying ; Rana, Dipen R. ; Cheng, Lawrence ; Lin, Alice T. ; Hughes, Gareth A. ; Zhang, Xiaojing J. ; Garner, Harold R. / Molecular profiling of individual tumor cells by hyperspectral microscopic imaging. In: Translational Research. 2012 ; Vol. 159, No. 5. pp. 366-375.
@article{ef52b58548a7477995077c79f9a26271,
title = "Molecular profiling of individual tumor cells by hyperspectral microscopic imaging",
abstract = "We developed a hyperspectral microscopic imaging (HMI) platform that can precisely identify and quantify 10 molecular markers in individual cancer cells in a single pass. The exploitation of an improved separation of circulating tumor cells and the application of HMI provided an opportunity (1) to identify molecular changes in these cells, (2) to recognize the coexpression of these markers, (3) to pose an important opportunity for noninvasive diagnosis, and (4) to use targeted therapy. We balanced the intensity of 10 fluorochromes bound to 10 different antibodies, each specific to a particular tumor marker, so that the intensity of each fluorochrome can be discerned from overlapping emissions. Using 2 touch preps from each primary breast cancer, the average molecular marker intensities of 25 tumor cells gave a representative molecular signature for the tumor despite some cellular heterogeneity. The intensities determined by the HMI correlate well with the conventional 0-3+ analysis by experts in cellular pathology. Because additional multiplexes can be developed using the same fluorochromes but different antibodies, this analysis allows quantification of many molecular markers on a population of tumor cells. HMI can be automated completely, and eventually, it could allow the standardization of protein biomarkers and improve reproducibility among clinical pathology laboratories.",
author = "Uhr, {Jonathan W.} and Huebschman, {Michael L.} and Frenkel, {Eugene P.} and Lane, {Nancy L.} and Raheela Ashfaq and Huaying Liu and Rana, {Dipen R.} and Lawrence Cheng and Lin, {Alice T.} and Hughes, {Gareth A.} and Zhang, {Xiaojing J.} and Garner, {Harold R.}",
year = "2012",
month = "5",
doi = "10.1016/j.trsl.2011.08.003",
language = "English (US)",
volume = "159",
pages = "366--375",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Molecular profiling of individual tumor cells by hyperspectral microscopic imaging

AU - Uhr, Jonathan W.

AU - Huebschman, Michael L.

AU - Frenkel, Eugene P.

AU - Lane, Nancy L.

AU - Ashfaq, Raheela

AU - Liu, Huaying

AU - Rana, Dipen R.

AU - Cheng, Lawrence

AU - Lin, Alice T.

AU - Hughes, Gareth A.

AU - Zhang, Xiaojing J.

AU - Garner, Harold R.

PY - 2012/5

Y1 - 2012/5

N2 - We developed a hyperspectral microscopic imaging (HMI) platform that can precisely identify and quantify 10 molecular markers in individual cancer cells in a single pass. The exploitation of an improved separation of circulating tumor cells and the application of HMI provided an opportunity (1) to identify molecular changes in these cells, (2) to recognize the coexpression of these markers, (3) to pose an important opportunity for noninvasive diagnosis, and (4) to use targeted therapy. We balanced the intensity of 10 fluorochromes bound to 10 different antibodies, each specific to a particular tumor marker, so that the intensity of each fluorochrome can be discerned from overlapping emissions. Using 2 touch preps from each primary breast cancer, the average molecular marker intensities of 25 tumor cells gave a representative molecular signature for the tumor despite some cellular heterogeneity. The intensities determined by the HMI correlate well with the conventional 0-3+ analysis by experts in cellular pathology. Because additional multiplexes can be developed using the same fluorochromes but different antibodies, this analysis allows quantification of many molecular markers on a population of tumor cells. HMI can be automated completely, and eventually, it could allow the standardization of protein biomarkers and improve reproducibility among clinical pathology laboratories.

AB - We developed a hyperspectral microscopic imaging (HMI) platform that can precisely identify and quantify 10 molecular markers in individual cancer cells in a single pass. The exploitation of an improved separation of circulating tumor cells and the application of HMI provided an opportunity (1) to identify molecular changes in these cells, (2) to recognize the coexpression of these markers, (3) to pose an important opportunity for noninvasive diagnosis, and (4) to use targeted therapy. We balanced the intensity of 10 fluorochromes bound to 10 different antibodies, each specific to a particular tumor marker, so that the intensity of each fluorochrome can be discerned from overlapping emissions. Using 2 touch preps from each primary breast cancer, the average molecular marker intensities of 25 tumor cells gave a representative molecular signature for the tumor despite some cellular heterogeneity. The intensities determined by the HMI correlate well with the conventional 0-3+ analysis by experts in cellular pathology. Because additional multiplexes can be developed using the same fluorochromes but different antibodies, this analysis allows quantification of many molecular markers on a population of tumor cells. HMI can be automated completely, and eventually, it could allow the standardization of protein biomarkers and improve reproducibility among clinical pathology laboratories.

UR - http://www.scopus.com/inward/record.url?scp=84859705839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859705839&partnerID=8YFLogxK

U2 - 10.1016/j.trsl.2011.08.003

DO - 10.1016/j.trsl.2011.08.003

M3 - Article

C2 - 22500509

AN - SCOPUS:84859705839

VL - 159

SP - 366

EP - 375

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 5

ER -